BP-015

BP-015 is a pediatric antiemetic formulation developed by Brillian Pharma, utilizing their proprietary "Unidose" drug delivery technology. It is designed as a lyophilized powder that is reconstituted into an oral suspension for single-dose administration. The product aims to improve dosing accuracy and ease of use for children suffering from nausea and vomiting. As a reformulation of an existing antiemetic agent, BP-015 focuses on enhancing the delivery and patient experience rather than introducing a new molecular entity. The formulation is specifically tailored for pediatric populations where traditional solid dosage forms may be unsuitable.